Helicobacter Pylori detection

PreclinicalBiologic

UUniversity Hospital Center of Martinique

Helicobacter Pylori detection is one of 14 biologic programs targeting Gastric Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Gastric CancerActive, not recruiting

Gastric CancerPreclinical

Active, not recruiting

Competition

Competitive Landscape

714 competitors in Gastric Cancer

#DrugCompanyPhaseTrials

S-1 Plus Oxaliplatin

FFudan University

Phase 3

2 2

Gemzar

Johnson & Johnson

Preclinical

—3

Ftorafur

TThe First Affiliated Hospital with Nanjing Medical University

Preclinical

3 4

S1,

CChinese Academy of Medical Sciences

Preclinical

17 5

PD-1 Inhibitor

Johnson & Johnson

Preclinical

3 6

Induction Phase1

Genmab

Preclinical

1 7

Glutamine

Sanofi

Preclinical

1 8

Human Albumin

TTonghua Anrate Biopharmaceutical Co., Ltd.

Preclinical

1 9

CEA-Targeted CAR-T Cells

CChongqing Precision Biotech Co., Ltd

Preclinical

1 10

Cox-2 Inhibitor

SSeoul National University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

Not yet recruiting

Gastric Cancer

NCT04949737

Clinical

Trials by Indication[1]

Gastric Cancer1 trial

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

Not yet recruiting·UUniversity Hospital Center of Martinique··NCT04949737·112 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Helicobacter Pylori detection. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Helicobacter Pylori detection compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Helicobacter Pylori detection. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital Center of Martinique company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital Center of Martinique

Helicobacter Pylori detection

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Gastric Cancer1 trial

References

Drug Info

Quick Facts

Related News